Boivin G - Search Results

1

Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib.

Niesor EJ, Boivin G, Rhéaume E, Shi R, Lavoie V, Goyette N, Picard ME, Perez A, Laghrissi-Thode F, Tardif JC. Niesor EJ, et al. Among authors: boivin g. ACS Omega. 2021 Jun 17;6(25):16584-16591. doi: 10.1021/acsomega.1c01797. eCollection 2021 Jun 29. ACS Omega. 2021. PMID: 34235330 Free PMC article.

2

A case of ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with AIDS: longitudinal molecular analysis of the CMV viral load and viral mutations in blood compartments.

Boivin G, Gilbert C, Morissette M, Handfield J, Goyette N, Bergeron MG. Boivin G, et al. AIDS. 1997 Jun;11(7):867-73. doi: 10.1097/00002030-199707000-00005. AIDS. 1997. PMID: 9189211

3

Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults.

Boivin G, Goyette N, Hardy I, Aoki F, Wagner A, Trottier S. Boivin G, et al. J Infect Dis. 2000 Apr;181(4):1471-4. doi: 10.1086/315392. Epub 2000 Apr 13. J Infect Dis. 2000. PMID: 10762579 Clinical Trial.

4

Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation.

Boivin G, Bélanger R, Delage R, Béliveau C, Demers C, Goyette N, Roy J. Boivin G, et al. J Clin Microbiol. 2000 Dec;38(12):4356-60. doi: 10.1128/JCM.38.12.4356-4360.2000. J Clin Microbiol. 2000. PMID: 11101564 Free PMC article.

5

Molecular evolution of influenza A/H3N2 viruses in the province of Québec (Canada) during the 1997-2000 period.

Hardy I, Li Y, Coulthart MB, Goyette N, Boivin G. Hardy I, et al. Among authors: boivin g. Virus Res. 2001 Sep;77(1):89-96. doi: 10.1016/s0168-1702(01)00269-6. Virus Res. 2001. PMID: 11451491

6

Syncytium formation and HIV-1 replication are both accentuated by purified influenza and virus-associated neuraminidase.

Sun J, Barbeau B, Sato S, Boivin G, Goyette N, Tremblay MJ. Sun J, et al. Among authors: boivin g. J Biol Chem. 2002 Mar 22;277(12):9825-33. doi: 10.1074/jbc.M110764200. Epub 2002 Jan 7. J Biol Chem. 2002. PMID: 11781317 Free article.

7

Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient.

Boivin G, Goyette N, Bernatchez H. Boivin G, et al. Clin Infect Dis. 2002 Mar 1;34(5):E23-5. doi: 10.1086/338870. Epub 2002 Jan 23. Clin Infect Dis. 2002. PMID: 11807683

8

Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors.

Boivin G, Goyette N. Boivin G, et al. Antiviral Res. 2002 Jun;54(3):143-7. doi: 10.1016/s0166-3542(01)00219-4. Antiviral Res. 2002. PMID: 12062387

9

Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients.

Boivin G, Goyette N, Gilbert C, Roberts N, Macey K, Paya C, Pescovitz MD, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Covington E. Boivin G, et al. J Infect Dis. 2004 May 1;189(9):1615-8. doi: 10.1086/382753. Epub 2004 Apr 13. J Infect Dis. 2004. PMID: 15116297 Clinical Trial.

10

A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus.

Abed Y, Goyette N, Boivin G. Abed Y, et al. Among authors: boivin g. Antivir Ther. 2004 Aug;9(4):577-81. Antivir Ther. 2004. PMID: 15456089

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

739 results

Search Page